Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

NCT01204918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: Riluzole
DRUG: placebo

Sponsor

Yale University